Verquvo – Heart Failure – Display Banners HCP Wallboard Extension_Early Adopter – 26101

Dapagliflozin Cuts CV Risk in HF With Preserved LVEF

For patients with HF with mildly reduced or preserved ejection fraction, the sodium glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin reduces the combined risk for worsening HF or cardiovascular death, according to a study...

Acetazolamide Helps Treat Volume Overload in HF

For patients with acute decompensated HF, the addition of acetazolamide to loop diuretic therapy yields an increased incidence of successful decongestion, according to a study published in the New England Journal of Medicine....

Remote Patient Monitoring: It’s Easier Than You Think

A 2021 survey of hospitals and clinics found that 20% and 23%, respectively, had either already adopted remote patient monitoring (RPM) or planned to do so within 12 months. Individual physicians, however, have been somewhat...



For latest news and updates
Email-id is invalid